
Yuji Uehara/X
Mar 6, 2025, 10:22
Yuji Uehara: TKIs for non-small cell lung cancer with EGFR exon 19 insertions
Yuji Uehara, Medical Oncologist at National Cancer Center Japan, shared a post on X about a paper he co-authored with colleagues published in Lung Cancer Journal:
“Hot off the press Lung Cancer Journal from LC-SCRUM and Thoracic Medical Oncology BIDMC:
- Rare EGFR exon 19 insertions (0.1% NSCLC); missed by PCR
- 2nd-gen EGFR-TKIs most effective
- Confirmed by in vitro/in silico.
Great thanks to Susumu Kobayashi.”
Authors: Yuji Uehara, Hiroki Izumi, Ikei Kobayashi, Susumu Kobayashi, Koichi Goto et al.
More posts featuring Yuji Uehara.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 6, 2025, 10:13
Mar 6, 2025, 10:09
Mar 6, 2025, 10:00
Mar 6, 2025, 09:56
Mar 6, 2025, 09:52
Mar 6, 2025, 09:31
Mar 6, 2025, 09:03
Mar 6, 2025, 08:52